Document:

Exhibit
      10.23

    

    CONSULTING
      AGREEMENT

    

    

    

    This
      Agreement is made effective as of September 01, 2005, by and between Aspect
      Systems, Inc., of 375 E. Elliot Rd., Chandler, Arizona 85225, and Douglas N.
      Dixon, of 2187 E. Victor Rd., Gilbert, Arizona 85296.

    

    In
      this
      Agreement, the party who is contracting to receive services shall be referred
      to
      as “ASI”,
      and the
      party who will be providing the services shall be referred to as “DN
      Dixon”.

    

    DN
      Dixon
      has a background in Sales and Marketing and is willing to provide services
      to
      ASI based on this background.

    

    ASI
      desires to have services provided by DN Dixon.

    

    Therefore,
      the parties agree as follows:

    

    1.
      DESCRIPTION OF SERVICES.
      Beginning on September 01, 2005, DN Dixon will provide the following services
      (collectively, the “Services”):
      Provide a method to market and sell ASI products that are being sold below
      standard sales pricing. These sales need to be handled in such a way that the
      world wide market is aware of the items being sold and for what price they
      are
      being offered.

    

    2.
      PERFORMANCE OF SERVICES. The
      manner in which the Services are to be performed and the specific hours to
      be
      worked by DN Dixon shall be determined by DN Dixon. ASI will rely on DN Dixon
      to
      work as many hours as may be reasonably necessary to fulfill DN
      Dixon’s
      obligations under this Agreement.

    

    3.
      PAYMENT. ASI
      will
      pay a fee to DN Dixon for the Services in the amount of $24,100.00. This fee
      shall be payable in a lump sum upon completion of the Services.

    

    4.
      EXPENSE REIMBURSEMENT. DN
      Dixon
      shall pay all “out-of-pocket”
      expenses, and shall not be entitled to reimbursement from ASI.

    

    5.
      SUPPORT SERVICES.
      ASI will
      not provide support services, including office space and secretarial services,
      for the benefit of DN Dixon. 

    

    6.
      NEW PROJECT APPROVAL. DN
      Dixon
      and ASI recognize that DN Dixon’s
      Services will include working on various projects for ASI. DN Dixon shall obtain
      the approval of ASI prior to the commencement of a new project. 

    

    7.
      TERM/TERMINATION. This
      Agreement shall terminate automatically on November 30, 2006. 

    

    8.
      RELATIONSHIP OF PARTIES. It
      is
      understood by the parties that DN Dixon is an independent contractor with
      respect to ASI, and not an employee of ASI. ASI will not provide fringe
      benefits, including health insurance benefits, paid vacation, or any other
      employee benefit, for the benefit of DN Dixon. 

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    9.
      INTELLECTUAL PROPERTY. The
      following provisions shall apply with respect to copyrightable works, ideas,
      discoveries, inventions, applications for patents, and patents (collectively,
      “Intellectual
      Property”):

    

    a.
      Consultant’s
      Intellectual Property.
      DN
      Dixon does not personally hold any interest in any Intellectual
      Property.

    

    10.
      CONFIDENTIALITY.
      ASI
      recognizes that DN Dixon has and will have the following
      information:

    

    	-  	
            products

          

    	-  	
            prices

          

    	-  	
            apparatus

          

    	-  	
            costs

          

    	-  	
            business
              affairs

          

    	-  	
            technical
              information

          

    	-  	
            customer
              lists

          

    	-  	
            copyrights

          

    

    and
      other
      propriety information (collectively, “Information”)
      which
      are valuable, special and unique assets of Aspect Systems, Inc. and need to
      be
      protected from improper disclosure. In consideration for the disclosure of
      the
      Information, DN Dixon agrees that DN Dixon will not at any time or in any
      manner, either directly or indirectly, use any Information for DN
      Dixon’s
      own
      benefit, or divulge, disclose, or communicate in any manner any Information
      to
      any third party without the prior written consent of ASI. DN Dixon will protect
      the Information and treat it as strictly confidential. A violation of this
      paragraph shall be a material violation of this Agreement.

    

    11.
      CONFIDENTIALITY AFTER TERMINATION.
      The
      confidentiality provisions of this Agreement shall remain in full force and
      effect after the termination of this Agreement.

    

    12.
      RETURN OF RECORDS. Upon
      termination of this Agreement, DN Dixon shall deliver all records, notes, data,
      memoranda, models, and equipment of any nature that are in DN Dixon’s
      possession or under DN Dixon’s
      control
      and that are ASI’s
      property or relate to ASI’s
      business. 

    

    13.
      NOTICES.
      All
      notices required or permitted under this Agreement shall be in writing and
      shall
      be deemed delivered when delivered in person or deposited in the United States
      mail, postage prepaid, addressed as follows: 

    

    IF
      for
      ASI:

    

    Aspect
      Systems, Inc.

    G.
      Dennis
      Key

    President/CEO

    375
      E.
      Elliot Rd.

    Chandler,
      Arizona 85225

    

    IF
      for DN
      Dixon:

    

    Douglas
      N. Dixon

    2187
      E.
      Victor Rd.

    Gilbert,
      Arizona 85296

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    Said
      addresses may be changed from time to time by either party by providing written
      notice to the other in the manner set forth above.

    

    14.
      ENTIRE AGREEMENT.
      This
      Agreement contains the entire agreement of the parties and there are no other
      promises or conditions in any other agreement whether oral or written. This
      Agreement supersedes any prior written or oral agreements between the parties.
      

    

    15.
      AMENDMENT. This
      Agreement may be modified or amended if the amendment is made in writing and
      is
      signed by both parties. 

    

    16.
      SEVERABILITY.
      If any
      provision of this Agreement shall be held to be invalid or unenforceable for
      any
      reason, the remaining provisions shall continue to be valid and enforceable.
      If
      a court finds that any provision of this Agreement is invalid unenforceable,
      but
      that by limiting such provision it would become valid and enforceable, then
      such
      provision shall be deemed to be written, construed, and enforced as so
      limited.

    

    17.
      WAIVER OF CONTRACTUAL RIGHT.
      The
      failure of either party to enforce any provision of this Agreement shall not
      be
      construed as a waiver or limitation of that party’s
      right
      to subsequently enforce and compel strict compliance with every provision of
      this Agreement.

    

    18.
      APPLICABLE LAW. This
      Agreement shall be governed by the laws of the State of Arizona.

    

    Party
      receiving services:

    Aspect
      Systems, Inc. 

    
      	 	 	 	 
	By:
              /s/ Dennis Key	 	 	 
	
              

              Dennis
                Key

              President/CEO

            	 	 	
            

    

     

    Party
      providing services:

    
      Douglas
        N. Dixon

    

    
      	 	 	 	 
	
              By:
                /s/ Douglas N. Dixon

            	 	 	 
	
              
Shareholder
              Douglas
                N. DixonFORM OF NOTE
      PURCHASE AGREEMENT

     

    THIS
      NOTE
      PURCHASE AGREEMENT (“Agreement”) is made as of January __, 2006, by and among
Health
      Partnership Inc.,
      a
      Colorado corporation, (the “Company”), and the lenders (each individually a
“Lender,” and collectively the “Lenders”) named on the Schedule of Lenders
      attached hereto (the “Schedule of Lenders”). Capitalized terms not otherwise
      defined in this Agreement shall have the meanings ascribed to them in Section
      1
      below.

     

    WHEREAS,
      each of the Lenders intends to provide certain Consideration to the Company
      as
      described for each Lender on the Schedule of Lenders; 

     

    WHEREAS,
      the parties wish to provide for the sale and issuance of the Notes in return
      for
      the provision by the Lenders of the Consideration to the Company on the terms
      and subject to the conditions set forth in this Agreement; and

     

    WHEREAS,
      the Company has obtained the written consent of Gerard Jacobs in connection
      with
      the sale and issuance of the Notes pursuant to that certain Note Purchase
      Agreement, dated October 31, 2005 by the Company and each lender named therein,
      a copy of which consent is attached hereto as Exhibit A. 

     

    NOW,
      THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS:

     

    1.  Definitions.

     

    (a)  “Common
      Stock” shall mean the common stock, par value $.0001, of the
      Company.

     

    (b)  “Consideration”
      shall mean the amount of money paid by each Lender pursuant to this Agreement
      as
      shown on the Schedule of Lenders.

     

    (c)  “Equity
      Securities” shall mean the Company’s Common Stock or Preferred Stock or any
      securities conferring the right to purchase the Company’s Preferred Stock or
      securities convertible into, or exchangeable for (with or without additional
      consideration), the Company’s Common Stock or Preferred Stock, except any
      security granted, issued and/or sold by the Company to any director, officer,
      employee or consultant of the Company in such capacity for the primary purpose
      of soliciting or retaining their services.

     

    (d)  “Knowledge”
      shall mean the actual knowledge of any officer of the Company.

     

    (e)  “Majority
      Note Holders” shall mean the holders of a majority in interest of the aggregate
      principal amount of Notes.

     

    (f)  “Maturity
      Date” shall mean the earlier of October 31, 2006 or the initial closing on
      Company issuance of equity.

     

    (g)  “Notes”
      shall mean the one or more unsecured promissory notes issued to each Lender
      pursuant to Section 2.1 below, the form of which is attached hereto as Exhibit
      B.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (h)  “Preferred
      Stock” shall mean the preferred stock, par value $0.10, of the
      Company.

     

    (i)  “Securities”
      shall have the meaning set forth in Section 5.2 below.

     

    2.  Terms
      of the Notes.

     

    2.1  Issuance
      of Notes.
      In
      return for the Consideration paid by each Lender, the Company shall sell and
      issue to such Lender one or more unsecured Notes in the aggregate amount up
      to
      $1,000,000 (or such increased amount as determined by the Company’s board of
      directors). Each Note shall have a principal balance equal to that portion
      of
      the Consideration paid by such Lender for the Note, as set forth in the Schedule
      of Lenders. Notwithstanding anything to the contrary herein, there shall be
      no
      minimum aggregate principal amount of the Notes which must be sold by the
      Company to any one or more Lenders before the Company can consummate the First
      Closing (as defined herein) or utilize the proceeds of the respective
      Consideration received by the Company at the First Closing or any Subsequent
      Closing (as defined herein).

     

    3.  Closing.
      The
      initial closing (the “First Closing”) of the purchase of the Notes in the
      amounts set forth opposite each Lender’s name on the Schedule of Lenders shall
      take place at the offices of the Company at 12:00 p.m., on ____________, 2006,
      or at such other time and place as the Company and Lenders purchasing the
      aggregate principal amount of the Notes to be sold at the First Closing agree
      upon orally or in writing. Any subsequent closing of the purchase of the Notes
      (a “Subsequent Closing”) in the amounts set forth opposite each Lender’s name on
      the Schedule of Lenders shall take place at such locations and at such times
      as
      shall be mutually agreed upon orally or in writing by the Company and Lenders
      purchasing the aggregate principal amount of the Notes to be sold at such
      Subsequent Closing. At each Closing, each Lender shall deliver the Consideration
      to the Company and the Company shall deliver to each Lender one or more executed
      Notes in return for the respective Consideration provided to the Company.

     

    4.  Representations
      and Warranties of the Company.
      In
      connection with the transactions provided for herein, the Company hereby
      represents and warrants to the Lenders that:

     

    4.1  Organization,
      Good Standing and Qualification.
      The
      Company is a corporation duly organized, validly existing, and in good standing
      under the laws of the State of Colorado and has all requisite corporate power
      and authority to carry on its business as now conducted. The Company is duly
      qualified to transact business and is in good standing in each jurisdiction
      in
      which the failure to so qualify would have a material adverse effect on its
      business or properties.

     

    4.2  Authorization.
      All
      corporate action has been taken on the part of the Company, its officers,
      directors and stockholders necessary for the authorization, execution, delivery
      and performance, of this Agreement and the Notes. Except as may be limited
      by
      applicable bankruptcy, insolvency, reorganization, or similar laws relating
      to
      or affecting the enforcement of creditors’ rights, the Company has taken all
      corporate action required to make all of the obligations of the Company
      reflected in the provisions of this Agreement and the Notes the valid and
      enforceable obligations they purport to be.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    4.3  Compliance
      with Other Instruments.
      Neither
      the authorization, execution and delivery of this Agreement or the Notes, nor
      the issuance and delivery of the Notes, will constitute or result in a default
      or violation of any law or regulation applicable to the Company or any term
      or
      provision of the Company’s current Articles or Bylaws or any material agreement
      or instrument by which it is bound or to which its properties or assets are
      subject.

     

    4.4  Valid
      Issuance.
      The
      Notes when issued, will be duly and validly issued, fully paid and nonassessable
      and, based in part upon the representations and warranties of the Lenders in
      this Agreement, and will be issued in compliance with all applicable federal
      and
      state securities laws.

     

    4.5  No
      Violation.
      The
      Company is not in violation of any order of any court, arbitrator or
      governmental body, material laws, ordinances or governmental rules or
      regulations (domestic or foreign) to which it is subject, or with respect to
      any
      material loan agreement, debt instrument or contract with a supplier or customer
      of the Company or other agreement to which it is a party and has not failed
      to
      obtain or apply for any licenses, permits, franchises or other governmental
      authorizations necessary to the ownership of its property or to the conduct
      of
      its business.

     

    4.6  No
      Litigation.
      There
      are no suits or proceedings pending or, to the Knowledge of the Company,
      threatened in any court or before any regulatory commission, board or other
      governmental administrative agency against or affecting the Company which if
      determined adversely to the Company could result in a material adverse effect
      on
      the Company’s business as presently conducted or its ability to perform its
      obligations hereunder or under the Notes.

     

    4.7  Arms’
      Length Transactions.
      The
      transactions evidenced by this Agreement and the Notes and the other documents
      and instruments delivered in connection herewith or therewith (a) are the result
      of arms’ length negotiations among the parties hereto, (b) are made on
      commercially reasonable terms, and (c) are undertaken by the Company without
      any
      intent to hinder, delay or defraud any entity to which the Company is or may
      become indebted.

     

    5.  Representations
      and Warranties of the Lenders.
      In
      connection with the transactions provided for herein, each Lender hereby
      represents and warrants to the Company that:

     

    5.1  Authorization.
      This
      Agreement constitutes such Lender’s valid and legally binding obligation,
      enforceable in accordance with its terms, except as may be limited by (a)
      applicable bankruptcy, insolvency, reorganization, or similar laws relating
      to
      or affecting the enforcement of creditors’ rights, and (c) laws relating to the
      availability of specific performance, injunctive relief or other equitable
      remedies. Each Lender represents that the execution, delivery and performance
      of
      this Agreement has been duly authorized and approved by such
      Lender.

     

    5.2  Purchase
      Entirely for Own Account.
      Each
      Lender acknowledges that this Agreement is made with Lender in reliance upon
      such Lender’s representation to the Company that the Notes (collectively, the
“Securities”) will be acquired for investment for Lender’s own account, as
      principal and not as a nominee or agent, and not with a view to the resale
      or
      distribution of any part thereof, and that such Lender has no present intention
      of selling, granting any participation in, or otherwise distributing the same.
      By executing this Agreement, each Lender further represents that such Lender
      does not have any contract, undertaking, agreement or arrangement with any
      person to sell, transfer or grant participations to such person or to any third
      person, with respect to the Securities.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    5.3  Disclosure
      of Information.
      Each
      Lender acknowledges that it has received all the information, documents and
      materials it considers necessary or appropriate for deciding whether to acquire
      the Securities. Each Lender confirms that it has made such further investigation
      of the Company as was deemed appropriate to evaluate the merits and risks of
      this investment. Each Lender further represents that it has had an opportunity
      to ask questions and receive answers from the Company regarding the terms and
      conditions of the offering of the Securities.

     

    5.4  Investment
      Experience.
      Each
      Lender is an investor in securities of companies in the development stage and
      acknowledges that it is able to fend for itself, can bear the economic risk
      of
      its investment and has such knowledge and experience in financial or business
      matters that it is capable of evaluating the merits and risks of the investment
      in the Securities. If other than an individual, each Lender also represents
      it
      has not been organized solely for the purpose of acquiring the
      Securities.

     

    5.5  Accredited
      Investor.
      Each
      Lender is an “accredited investor” within the meaning of Rule 501 of Regulation
      D of the Securities Act of 1933, as presently in effect (the “Securities
      Act”).

     

    5.6  Restricted
      Securities.
      Each
      Lender understands that the Securities are characterized as “restricted
      securities” under the federal securities laws inasmuch as they are being
      acquired from the Company in a transaction not involving a public offering
      and
      that under such laws and applicable regulations such securities may not be
      resold except through a valid registration statement or pursuant to a valid
      exemption from the registration requirements under the Securities Act and
      applicable state securities laws. Each Lender represents that it is familiar
      with Rule 144 of the Securities Act, and understands the resale limitations
      imposed thereby and by the Securities Act and applicable state securities
      laws.

     

    5.7  Further
      Limitations on Disposition.
      Without
      in any way limiting the representations and warranties set forth above, each
      Lender further agrees not to make any disposition of all or any portion of
      the
      Securities unless and until the transferee has agreed in writing for the benefit
      of the Company to be bound by this Section 5 and:

     

    (a)  There
      is
      then in effect a registration statement under the Securities Act covering such
      proposed disposition and such disposition is made in accordance with such
      registration statement; 

     

    (b)  (i)Lender
      has notified the Company of the proposed disposition and has furnished the
      Company with a detailed statement of the circumstances surrounding the proposed
      disposition and (ii) if reasonably requested by the Company, Lender shall have
      furnished the Company with an opinion of counsel, reasonably satisfactory to
      the
      Company, that such disposition will not require registration of such shares
      under the Securities Act; or

     

    (c)  All
      transferees agree in writing to be subject to the terms hereof, and any other
      agreements to which such Securities may be subject, to the same extent as if
      they were Lenders hereunder.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    5.8  Legends.
      It is
      understood that the certificates evidencing the Securities, or any other
      securities issued in respect of the Securities upon any stock split, stock
      dividend, recapitalization, merger, consolidation or similar event, shall bear
      the legends required by applicable law as well as such agreements to which
      such
      Securities may be subject, including, without limitation, legends relating
      to
      restrictions on transfer under federal and state securities laws and legends
      required under applicable state securities laws, as well as the following
      legend: 

     

    “THESE
      SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
      (THE “SECURITIES ACT”), OR REGISTERED UNDER ANY STATE SECURITIES LAWS. THEY MAY
      NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED
      EXCEPT PURSUANT TO (A) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
      ACT OF 1933, AS AMENDED, (B) AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY
      THAT REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT, OR (C) AN EXEMPTION
      FROM REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER
      (IF
      AVAILABLE), IN EACH OF CASES (A) THROUGH (C) IN ACCORDANCE WITH ANY APPLICABLE
      STATE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES.”

     

    6.  Defaults
      and Remedies.

     

    6.1  Events
      of Default.
      The
      following events shall be considered Events of Default with respect to each
      Note:

     

    (a)  The
      Company shall default in the payment of any part of the principal or unpaid
      accrued interest on any Note for more than thirty (30) days after the Maturity
      Date or at a date fixed by acceleration or otherwise;

     

    (b)  The
      Company shall make an assignment for the benefit of creditors, or shall admit
      in
      writing its inability to pay its debts as they become due, or shall file a
      voluntary petition for bankruptcy, or shall file any petition or answer seeking
      for itself any reorganization, arrangement, composition, readjustment,
      dissolution or similar relief under any present or future statute, law or
      regulation, or shall file any answer admitting the material allegations of
      a
      petition filed against the Company in any such proceeding, or shall seek or
      consent to or acquiesce in the appointment of any trustee, receiver or
      liquidator of the Company, or of all or any substantial part of the properties
      of the Company, or the Company or its respective directors or majority
      stockholders shall take any action looking to the dissolution or liquidation
      of
      the Company; 

     

    (c)  Within
      sixty (60) days after the commencement of any proceeding against the Company
      seeking any bankruptcy reorganization, arrangement, composition, readjustment,
      liquidation, dissolution or similar relief under any present or future statute,
      law or regulation, such proceeding shall not have been dismissed, or within
      sixty (60) days after the appointment without the consent or acquiescence of
      the
      Company of any trustee, receiver or liquidator of the Company or of all or
      any
      substantial part of the properties of the Company, such appointment shall not
      have been vacated; or

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (d)  The
      Company shall fail to observe or perform any other obligation to be observed
      or
      performed by it under this Agreement or the Notes within 30 (thirty) days after
      written notice from the Majority Note Holders to perform or observe the
      obligation, or any representation or warranty made by the Company hereunder
      or
      thereunder shall be false in any material respect as of the date made and such
      representation or warranty is not cured, if susceptible to cure, within 30
      (thirty) days after the Company’s Knowledge of such failure.

     

    6.2  Remedies.
      Upon
      the occurrence of an Event of Default under Section 6.1 hereof, at the option
      and upon the declaration of the holder of a Note, the entire unpaid principal
      and accrued and unpaid interest on such Note, and all other amounts owing under
      this Agreement shall, without presentment, demand, protest, or notice of any
      kind, all of which are hereby expressly waived, be forthwith due and payable,
      and such holder may, immediately and without expiration of any period of grace,
      enforce payment of all amounts due and owing under such Note and exercise any
      and all other remedies granted to it at law, in equity or otherwise; provided,
      however, that if any Event of Default occurs under Sections 6.1(b) or 6.1(c),
      all unpaid principal and accrued and unpaid interest on such Note, and all
      other
      amounts owing under this Agreement, shall automatically become immediately
      due
      and payable. Notwithstanding anything herein to the contrary, any payments
      under
      the Notes shall be made to all Holder on a pari
      passu.

     

    7.  Miscellaneous.

     

    7.1  Successors
      and Assigns.
      Except
      as otherwise provided herein, the terms and conditions of this Agreement shall
      inure to the benefit of and be binding upon the respective successors and
      assigns of the parties, provided, however, that the Company may not assign
      its
      obligations under this Agreement without the written consent of the Majority
      Note Holders (which shall not be unreasonably withheld), and no Lender may,
      without the written consent of the Company (which shall not be unreasonably
      withheld), assign all or any portion of a Note to any person or entity. Nothing
      in this Agreement, express or implied, is intended to confer upon any party
      other than the parties hereto or their respective successors and assigns any
      rights, remedies, obligations or liabilities under or by reason of this
      Agreement, except as expressly provided in this Agreement.

     

    7.2  Governing
      Law.
      This
      Agreement and the Notes shall be governed by and construed under the laws of
      the
      State of Illinois as applied to agreements among Illinois residents, made and
      to
      be performed entirely within the State of Illinois.

     

    7.3  Counterparts.
      This
      Agreement, and any of the other agreements, documents and instruments
      contemplated hereby, may be executed in two or more counterparts, each of which
      shall be deemed an original, but all of which together shall constitute one
      and
      the same instrument. Delivery of an executed signature page to this Agreement,
      and any of the other Agreements, documents and instruments contemplated hereby,
      by facsimile transmission shall be effective as delivery of a manually signed
      counterpart hereof or thereof.

     

    7.4  Titles
      and Subtitles.
      The
      titles and subtitles used in this Agreement are used for convenience only and
      are not to be considered in construing or interpreting this
      Agreement.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    7.5  Notices.
      All
      notices and other communications given or made pursuant hereto shall be in
      writing and shall be deemed effectively given: (i) upon personal delivery to
      the
      party to be notified, (ii) when sent by confirmed electronic mail or facsimile
      if sent during normal business hours of the recipient, if not so confirmed,
      then
      on the next business day, (iii) five (5) days after having been sent by
      registered or certified mail, return receipt requested, postage prepaid or
      (iv)
      one (1) day after deposit with a nationally recognized overnight courier,
      specifying next day delivery, with written verification of receipt. All
      communications shall be sent to the respective parties at the following
      addresses (or at such other addresses as shall be specified by notice given
      in
      accordance with this Section 7.5):

     

    
      	
              If
                to the Company:

            	
              Health
                Partnership Inc.

              3111
                N. Seminary, Suite 1N

              Chicago,
                IL 60657

              Attention: Lee
                Wiskowski

            
	
               

            	 
	
              If
                to Lenders:

            	
              At
                the respective addresses shown on the Schedule of
                Lenders.

            

    

    

    7.6  Finder’s
      Fee.
      Each
      party represents that it neither is nor will be obligated for any finder’s fee
      or commission in connection with this transaction. Lender agrees to indemnify
      and to hold harmless the Company from any liability for any commission or
      compensation in the nature of a finder’s fee (and the costs and expenses of
      defending against such liability or asserted liability) for which Lender or
      any
      of its officers, partners, employees or representatives is responsible. The
      Company agrees to indemnify and hold harmless Lender from any liability for
      any
      commission or compensation in the nature of a finder’s fee (and the costs and
      expenses of defending against such liability or asserted liability) for which
      the Company or any of its officers, employees or representatives is
      responsible.

     

    7.7  Expenses.
      If any
      action at law or in equity is necessary to enforce or interpret the terms of
      this Agreement, the prevailing party shall be entitled to reasonable attorneys’
fees, costs and necessary disbursements in addition to any other relief to
      which
      such party may be entitled. The Company shall pay all costs and expenses that
      it
      incurs with respect to the negotiation, execution, delivery and performance
      of
      this Agreement.

     

    7.8  Entire
      Agreement; Amendments and Waivers.
      This
      Agreement and the Notes and the other documents delivered pursuant hereto
      constitute the full and entire understanding and agreement between the parties
      with regard to the subjects hereof and thereof. The Company’s agreements with
      each of the Lenders are separate agreements, and the sales of the Notes to
      each
      of the Lenders are separate sales. Nonetheless, any term of this Agreement
      or
      the Notes may be amended and the observance of any term of this Agreement or
      the
      Notes may be waived (either generally or in a particular instance and either
      retroactively or prospectively), with the written consent of the Company and
      the
      Majority Note Holders. Any waiver or amendment effected in accordance with
      this
      Section shall be binding upon each party to this Agreement and any holder of
      any
      Note purchased under this Agreement at the time outstanding and each future
      holder of all such Notes.

     

    7.9  Effect
      of Amendment or Waiver.
      Each
      Lender acknowledges that by the operation of Section 7.8 hereof, the Majority
      Note Holders will have the right and power to diminish or eliminate all rights
      of such Lender under this Agreement and each Note issued to such
      Lender.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    7.10  Severability.
      If one
      or more provisions of this Agreement are held to be unenforceable under
      applicable law, such provision shall be excluded from this Agreement and the
      balance of the Agreement shall be interpreted as if such provision were so
      excluded and shall be enforceable in accordance with its terms.

     

    7.11  Exculpation
      Among Lenders.
      Each
      Lender acknowledges that it is not relying upon any person, firm, corporation
      or
      stockholder, other than the Company and its officers and directors in their
      capacities as such, in making its investment or decision to invest in the
      Company. Each Lender agrees that no other Lender nor the respective controlling
      persons, officers, directors, partners, agents, stockholders or employees of
      any
      other Lender shall be liable for any action heretofore or hereafter taken or
      omitted to be taken by any of them in connection with the purchase and sale
      of
      the Securities.

     

    IN
      WITNESS WHEREOF, the parties have executed this Agreement as of the date first
      above written.

     

     

    
      	 	 	
              Health
                Partnership Inc.

            
	 	 	 
	 	 	 
	 	 	
              By:

            	 
	 	 	
              Name:

            	 
	 	 	
              Title:

            	 
	 	 	 
	 	 	 
	 	 	
              LENDERS:

            	 
	 	 	 	
              [Print
                Name]

            
	 	 	 
	 	 	
              Amount:

            	
              $

            	 
	 	 	 
	 	 	
              Address:

            	 
	 	 	 	 
	 	 	 

    

    

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    SCHEDULE
      OF LENDERS 

     

    
      	
               

              Lender

            	
               

              Total
                Consideration

            	 	
              Principal
                Balance of Promissory Note

            
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	
              Lenders’
                Addresses:

            	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 

    

    

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    EXHIBIT
      A

     

    CONSENT

     

    The
      undersigned acknowledges and agrees as follows:

     

    1. Health
      Partnership Inc. (the “Company”) proposes to sale and issue one or more
      unsecured promissory notes in the aggregate amount of $1,000,000 (or such
      increased amount as determined by the Company’s board of directors) to certain
      lenders to provide consideration to the Company (collectively, the “Contemplated
      Transactions”).

     

    2. Pursuant
      to Section 7.13 of that certain Note Purchase Agreement dated October 31, 2005
      by the Company and the lenders named on the Schedule of Lenders attached thereto
      (the “Note Purchase Agreement”), until the later of the Maturity Date or
      repayment of the Note (each as defined in the Note Purchase Agreement), the
      Company shall not take any action regarding, among others, the issuance of
      debt
      of more than $100,000 or Equity Securities (as defined in the Note Purchase
      Agreement) in any amount, without the express written consent of Gerard Jacobs,
      or, in the event of his death or incapacity, the trustee of the Roberti Jacobs
      Family Trust u/a/d 11-11-99.

     

    3. The
      undersigned hereby consents to the Contemplated Transactions upon the terms
      stated herein and all such further agreements, instruments, certificates,
      documents and other amendments related thereto or deemed necessary by the
      Company in order to carry out the Contemplated Transactions.

     

    4. This
      Consent is binding upon the successors and assigns of the
      undersigned.

     

    5. This
      Consent is governed by and construed in accordance with the laws of the State
      of
      Illinois, without regard to choice or conflict of laws principles.

     

    

    
      	
              Date:

            	 	 	 
	 	 	
              Gerard
                Jacobs

            

    

    

     

    
      
        
          A-1

        

        
        

      

      
        
        

        
          

        

      

      
        
        

        
        

      

    

    EXHIBIT
      B

     

    FORM
      OF PROMISSORY NOTE

     

    THIS
      PROMISSORY NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
      AMENDED (THE ”SECURITIES ACT”), OR REGISTERED UNDER ANY STATE SECURITIES LAWS.
      THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE
      TRANSFERRED EXCEPT PURSUANT TO (A) AN EFFECTIVE REGISTRATION STATEMENT UNDER
      THE
      SECURITIES ACT OF 1933, AS AMENDED, (B) AN OPINION OF COUNSEL SATISFACTORY
      TO
      THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT, OR
      (C)
      AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144
      THEREUNDER (IF AVAILABLE), IN EACH OF CASES (A) THROUGH (C) IN ACCORDANCE WITH
      ANY APPLICABLE STATE SECURITIES LAWS OF ANY STATE OF THE UNITED
      STATES.

     

    PROMISSORY
      NOTE

     

    
      	
              No.

            	 	 	
              Date
                of Issuance:

            	
              January
                __, 2006

            
	 
	
              $

            	 	 	 	 

    

    

    FOR
      VALUE
      RECEIVED, Health Partnership Inc., a Colorado corporation (the “Company”),
      hereby promises to pay to __________________ (the “Lender”), the principal sum
      of _________________ Dollars ($______), together with interest thereon from
      the
      date of this Promissory Note (the “Promissory Note”). Interest shall accrue at a
      rate of twelve percent (12%) per annum. The principal amount and all accrued
      and
      unpaid interest shall be due and payable by the Company on the Maturity
      Date.

     

    This
      Promissory Note is one of the Notes issued pursuant to that certain Note
      Purchase Agreement dated as of January __, 2006, by and among the Company,
      the
      Lender and certain other parties, as amended, modified or supplemented from
      time
      to time (the “Purchase Agreement”), and capitalized terms not defined herein
      shall have the meaning set forth in the Purchase Agreement.

     

    1. Payment.
      All
      payments shall be made in lawful money of the United States of America at the
      principal office of the Company, or at such other place as the Lender may from
      time to time designate in writing to the Company. Payment shall be credited
      first to Costs (as defined below), if any, then to accrued interest due and
      payable and any remainder applied to principal. Prepayment of principal may
      be
      made at any time. In connection with the delivery, acceptance, performance
      or
      enforcement of this Promissory Note, the Company hereby waives demand, notice,
      presentment, protest, notice of dishonor and other notice of any kind, and
      asserts to extensions of the time of payment, release, surrender or substitution
      of security, or forbearance or other indulgence, without notice. The Company
      agrees to pay all amounts under this Promissory Note without offset, deduction,
      claim, counterclaim, defense or recoupment, all of which are hereby waived.
      All
      payments made under this Promissory Note and the Notes issued pursuant to the
      Purchase Agreement shall be made pro rata, based on the principal amount owing
      under the Notes.

     

    
      
         

      

      
        B-1

        
          

        

      

      
         

      

    

     

    2. Event
      of Default Interest.
      Upon
      the occurrence of an Event of Default pursuant to the Purchase Agreement, and
      continuing until such time as such Event of Default is cured, interest shall
      be
      due and payable on the whole of the unpaid principal balance at an annual rate
      of fourteen percent (14%) per annum, compounded annually. 

     

    3. Amendments
      and Waivers; Resolutions of Dispute; Notice.
      The
      amendment or waiver of any term of this Promissory Note, the resolution of
      any
      controversy or claim arising out of or relating to this Promissory Note and
      the
      provision of notice shall be conducted pursuant to the terms of the Purchase
      Agreement.

     

    4. Successors
      and Assigns.
      This
      Promissory Note applies to, inures to the benefit of, and binds the successors
      and assigns of the parties hereto; provided, however, that the Company may
      not
      assign its obligations under this Promissory Note without the written consent
      of
      the Majority Note Holders and the Lender may not, without the written consent
      of
      the Company (which shall not be unreasonably withheld), assign all or any
      portion of this Promissory Note. Any transfer of this Promissory Note may be
      effected only pursuant to the Purchase Agreement and by surrender of this
      Promissory Note to the Company and reissuance of a new note to the transferee.
      The Lender and any subsequent holder of this Promissory Note receives this
      Promissory Note subject to the foregoing terms and conditions, and agrees to
      comply with the foregoing terms and conditions for the benefit of the Company
      and any other Lenders.

     

    5. Officers
      and Directors not Liable.
      In no
      event shall any officer or director of the Company be liable for any amounts
      due
      and payable pursuant to this Promissory Note.

     

    6. Expenses.
      The
      Company hereby agrees, subject only to any limitation imposed by applicable
      law,
      to pay all expenses, including reasonable attorneys’ fees and legal expenses,
      incurred by the Lender (“Costs”) in endeavoring to collect any amounts payable
      hereunder which are not paid when due, whether by declaration or otherwise.
      The
      Company agrees that any delay on the part of the Lender in exercising any rights
      hereunder will not operate as a waiver of such rights. The Lender of this
      Promissory Note shall not by any act, delay, omission or otherwise be deemed
      to
      have waived any of its rights or remedies, and no waiver of any kind shall
      be
      valid unless in writing and signed by the party or parties waiving such rights
      or remedies.

     

    7. Governing
      Law.
      This
      Promissory Note shall be governed by and construed under the laws of the State
      of Illinois

     

    8. Approval.
      The
      Company hereby represents that its board of directors, in the exercise of its
      fiduciary duty, has approved the Company’s execution of this Promissory Note
      based upon a reasonable belief that the principal provided hereunder is
      appropriate for the Company after reasonable inquiry concerning the Company’s
      financing objectives and financial situation. 

     

    
      	 	 	
              Health
                Partnership Inc.

            
	 	 	 
	 	 	 
	 	 	
              By:

            	 
	 	 	
              Name:

            	 
	 	 	
              Title:

            	 

    

     

     

    
 

    
      
         

      

      
        
          B-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}]]